Article
type: Class

Document
type: Class

Anualidad
type: Class

Academic Article
type: Class

Information Content Entity
type: Class

Continuant
type: Class

2022
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-17T10:13:17
publisher: The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and beta-TrCP-NRF2 interactions in cancer chemoresistance
label: RDF description of The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and beta-TrCP-NRF2 interactions in cancer chemoresistance - http://research.umh.es/vivo/pub/articulo/241339

The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and beta-TrCP-NRF2 interactions in cancer chemoresistance
type: 2022
included: Bioquímica y Biología Molecular 2022
most specific type: 2022
related by: AutorExt:381272_2022-Artículo:241339
included: Compuestos bioactivos naturales 2022
included: Relaciones Estructura-función en Proteínas de Membrana 2022
type: Generically Dependent Continuant
type: Document
type: Academic Article
most specific type: Academic Article
page start: 246
related by: AutorExt:381270_2022-Artículo:241339
type: Information Content Entity
related by: AutorExt:381271_2022-Artículo:241339
ARG_2000028: 241339 vcard
related by: Autor:4203-Artículo:241339
date time value: 241339 pubdate
included: Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche 2022
related by: AutorExt:381269_2022-Artículo:241339
has publication venue: FREE RADICAL BIOLOGY AND MEDICINE
type: Thing
page end: 260
type: Anualidad
type: Continuant
type: Article
type: Entity

Bioquímica y Biología Molecular 2022
type: 2022
type: Anualidad
type: DepartmentReport
type: Thing
type: ResearchReport
includes: The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and beta-TrCP-NRF2 interactions in cancer chemoresistance

AutorExt:381272_2022-Artículo:241339
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and beta-TrCP-NRF2 interactions in cancer chemoresistance

Compuestos bioactivos naturales 2022
type: 2022
type: ResearchOrganizationReport
type: Anualidad
type: Thing
type: ResearchReport
includes: The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and beta-TrCP-NRF2 interactions in cancer chemoresistance

Relaciones Estructura-función en Proteínas de Membrana 2022
type: 2022
type: ResearchOrganizationReport
type: Anualidad
type: Thing
type: ResearchReport
includes: The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and beta-TrCP-NRF2 interactions in cancer chemoresistance

AutorExt:381270_2022-Artículo:241339
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and beta-TrCP-NRF2 interactions in cancer chemoresistance

AutorExt:381271_2022-Artículo:241339
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and beta-TrCP-NRF2 interactions in cancer chemoresistance

Autor:4203-Artículo:241339
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and beta-TrCP-NRF2 interactions in cancer chemoresistance

Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche 2022
type: InstituteReport
type: 2022
type: Anualidad
type: Thing
type: ResearchReport
includes: The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and beta-TrCP-NRF2 interactions in cancer chemoresistance

AutorExt:381269_2022-Artículo:241339
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and beta-TrCP-NRF2 interactions in cancer chemoresistance

FREE RADICAL BIOLOGY AND MEDICINE
type: Information Content Entity
type: Generically Dependent Continuant
type: Collection
type: Journal
publication venue for: The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and beta-TrCP-NRF2 interactions in cancer chemoresistance
type: Periodical
type: Entity
type: Thing
type: Continuant